课题基金 / 基金详情

LINEs of Mutagenesis, Selection and Evolution in Ovarian Cancer and Chemoresistance

LINEs of Mutagenesis, Selection and Evolution in Ovarian Cancer and Chemoresistance
卵巢癌的突变、选择和进化以及化疗耐药性
批准号:
nhmrc : 1130815
负责人:
Dr Kyle Upton
金额:
$29.04万
依托单位国家:
澳大利亚
项目类别:
Career Development Fellowships
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2020-12-31

项目摘要

项目成果

Dr Kyle Upton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
L1 elements are powerful mutagens encoded within the human genome that becomes active in epithelial tumours. I will define the broad effects of L1 elements on the evolution of chemoresistance, focusing on ovarian cancer as a model system. Ovarian cancer is characterised by a poor 5 year survival rate of ~40% with most tumours developing resistance. Understanding the impacts of L1 on this evolution will inform the development and selection of more effective treatments for ovarian cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A three-tiered strategy to prevent destabilisation of the induced pluripotent stem cell genome by L1 retrotransposition
  • 批准号:
    nhmrc : 1067983
  • 项目类别:
    Project Grants
  • 资助金额:
    $47.26万
  • 财政年份:
    2014
  • 负责人:
    Dr Kyle Upton
  • 依托单位:
Epigenetic regulation of L1 retrotransposition in mouse models of abnormal human neurobiology
  • 批准号:
    nhmrc : 1045991
  • 项目类别:
    Project Grants
  • 资助金额:
    $27.86万
  • 财政年份:
    2013
  • 负责人:
    Dr Kyle Upton
  • 依托单位:
海外基金